Quality of life and economic evaluation in SLE clinical trials.
- 1 October 1999
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 8 (8) , 645-654
- https://doi.org/10.1191/096120399680411344
Abstract
Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.Keywords
This publication has 48 references indexed in Scilit:
- Why health care costs more in the US: Comparing health care expenditures between systemic lupus erythematosus patients in Stanford and MontrealArthritis & Rheumatism, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- A canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costsArthritis & Rheumatism, 1993
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993
- The impact of rheumatoid arthritis on the household work performance of womenArthritis & Rheumatism, 1991
- Estimating Costs in the Economic Evaluation of Medical TechnologiesInternational Journal of Technology Assessment in Health Care, 1990
- The work dynamics of the person with rheumatoid arthritisArthritis & Rheumatism, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980